ARCHIVES

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

This article is from The Cancer Letter archive.

Vol. 12 No. 31 | August 1, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Panel Resumes Deliberations

January 4, 1980

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

AACR Plans Office in Singapore.

November 30, 2007

The March: AACR, AACI Compile List Of Activities Related To The March

May 8, 1998

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011